Essex Bio-Technology Limited

SEHK:1061 Voorraadrapport

Marktkapitalisatie: HK$1.5b

Essex Bio-Technology Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Haizhou Fang

Algemeen directeur

HK$1.7m

Totale compensatie

Percentage CEO-salaris97.5%
Dienstverband CEOno data
Eigendom CEO0.9%
Management gemiddelde ambtstermijn23.8yrs
Gemiddelde ambtstermijn bestuur4.2yrs

Recente managementupdates

How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Feb 15
How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Recent updates

Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement

Oct 09
Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement

Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's

Aug 29
Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's

Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

May 06
Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)

Mar 21
Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)

Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet

Dec 07
Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Dec 07
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04

Aug 25
Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04

Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?

Jun 22
Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?

Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055

May 02
Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055

Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055

Mar 30
Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Jun 29
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Is Essex Bio-Technology (HKG:1061) A Risky Investment?

Mar 31
Is Essex Bio-Technology (HKG:1061) A Risky Investment?

If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today

Mar 13
If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today

How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Feb 15
How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?

Jan 25
Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?

Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Jan 04
Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Dec 13
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters

Nov 23
Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters

Analyse CEO-vergoeding

Hoe is Haizhou Fang's beloning veranderd ten opzichte van Essex Bio-Technology's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

HK$263m

Mar 31 2024n/an/a

HK$269m

Dec 31 2023HK$2mHK$2m

HK$275m

Sep 30 2023n/an/a

HK$266m

Jun 30 2023n/an/a

HK$256m

Mar 31 2023n/an/a

HK$241m

Dec 31 2022HK$2mHK$2m

HK$225m

Sep 30 2022n/an/a

HK$274m

Jun 30 2022n/an/a

HK$323m

Mar 31 2022n/an/a

HK$334m

Dec 31 2021HK$2mHK$2m

HK$346m

Sep 30 2021n/an/a

HK$339m

Jun 30 2021n/an/a

HK$332m

Mar 31 2021n/an/a

HK$275m

Dec 31 2020HK$2mHK$2m

HK$219m

Sep 30 2020n/an/a

HK$221m

Jun 30 2020n/an/a

HK$222m

Mar 31 2020n/an/a

HK$262m

Dec 31 2019HK$2mHK$737k

HK$303m

Sep 30 2019n/an/a

HK$282m

Jun 30 2019n/an/a

HK$262m

Mar 31 2019n/an/a

HK$246m

Dec 31 2018HK$2mHK$766k

HK$231m

Sep 30 2018n/an/a

HK$210m

Jun 30 2018n/an/a

HK$189m

Mar 31 2018n/an/a

HK$178m

Dec 31 2017HK$2mHK$721k

HK$167m

Compensatie versus markt: De totale vergoeding ($USD 224.15K ) Haizhou } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 336.37K ).

Compensatie versus inkomsten: De vergoeding van Haizhou is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Haizhou Fang (58 yo)

no data

Tenure

HK$1,744,587

Compensatie

Mr. Haizhou Fang serves as the Managing Director and Executive Director of Essex Bio-Technology Limited and served as its General Manager. Mr. Fang is qualified as a Senior Pharmaceutical Engineer (Profess...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Mia Je Ngiam
Founder & Chairmanno dataHK$3.23m52.75%
HK$ 799.1m
Haizhou Fang
MD & Executive Directorno dataHK$1.74m0.92%
HK$ 14.0m
Hian Leng Ngiam
Executive Director & Deputy MDno dataHK$1.80m0.36%
HK$ 5.4m
Lai Man Yau
Executive Director & Company Secretary23.8yrsHK$755.60k0.0081%
HK$ 122.9k
Qi Xue
Group Chief Scientific Officer6.6yrsgeen gegevensgeen gegevens

23.8yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 1061 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 23.8 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Mia Je Ngiam
Founder & Chairmanno dataHK$3.23m52.75%
HK$ 799.1m
Haizhou Fang
MD & Executive Directorno dataHK$1.74m0.92%
HK$ 14.0m
Hian Leng Ngiam
Executive Director & Deputy MD4.2yrsHK$1.80m0.36%
HK$ 5.4m
Lai Man Yau
Executive Director & Company Secretary4.2yrsHK$755.60k0.0081%
HK$ 122.9k
Chi Ying Fung
Independent Non Executive Director23.4yrsHK$250.00kgeen gegevens
Mee Mooi Yeow
Independent Non Executive Director20.2yrsHK$220.00kgeen gegevens
Man Sing Yan
Independent Non-Executive Director1.4yrsHK$128.33kgeen gegevens

4.2yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 1061 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.2 jaar).